Abstract
Cancer is a systemic disease that induces functional dysregulation in multiple tissues and organs. The great majority of cancer-related deaths are due to metastasis, a multistep process involving crosstalk between cancer cells and stromal cells and immune cells in pre-metastatic niches (PMNs) at distant organs. As message carriers, extracellular vesicles and particles (EVPs) derived from cancer cells can modulate the phenotype of recipient cells by transferring various biomolecules, including nucleic acids, proteins, metabolites and lipids, thereby contributing to PMN formation and metastasis. In this chapter, we highlight the roles of cancer cell-derived EVPs in metastasis progression, with a focus on PMN establishment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
David, A.R., Zimmerman, M.R.: Cancer: an old disease, a new disease or something in between? Nat. Rev. Cancer. 10, 728–733 (2010)
Siegel, R.L., Miller, K.D., Jemal, A.: Cancer statistics, 2020. CA Cancer J. Clin. 70, 7–30 (2020)
Lambert, A.W., Pattabiraman, D.R., Weinberg, R.A.: Emerging biological principles of metastasis. Cell. 168, 670–691 (2017)
Obenauf, A.C., Massague, J.: Surviving at a distance: organ-specific metastasis. Trends Cancer. 1, 76–91 (2015)
Massague, J., Obenauf, A.C.: Metastatic colonization by circulating tumour cells. Nature. 529, 298–306 (2016)
Valastyan, S., Weinberg, R.A.: Tumor metastasis: molecular insights and evolving paradigms. Cell. 147, 275–292 (2011)
Peinado, H., et al.: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18, 883–891 (2012)
Costa-Silva, B., et al.: Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat. Cell Biol. 17, 816–826 (2015)
Hoshino, A., et al.: Tumour exosome integrins determine organotropic metastasis. Nature. 527, 329–335 (2015)
Rodrigues, G., et al.: Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis. Nat. Cell Biol. 21, 1403–1412 (2019)
Paget, S.: The distribution of secondary growths in cancer of the breast. Lancet. 133, 571–573 (1889)
Peinado, H., et al.: Pre-metastatic niches: organ-specific homes for metastases. Nat. Rev. Cancer. 17, 302–317 (2017)
Kaplan, R.N., et al.: VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 438, 820–827 (2005)
Wortzel, I., Dror, S., Kenific, C.M., Lyden, D.: Exosome-mediated metastasis: communication from a distance. Dev. Cell. 49, 347–360 (2019)
Elia, I., et al.: Breast cancer cells rely on environmental pyruvate to shape the metastatic niche. Nature. 568, 117–121 (2019)
Liu, Y., et al.: Tumor exosomal RNAs promote lung pre-metastatic niche formation by activating Alveolar epithelial TLR3 to recruit neutrophils. Cancer Cell. 30, 243–256 (2016)
Fong, M.Y., et al.: Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nat. Cell Biol. 17, 183–194 (2015)
Zhou, W., et al.: Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell. 25, 501–515 (2014)
Wang, S.E.: Extracellular vesicles and metastasis. Cold Spring Harb. Perspect. Med. (2019)
Mathieu, M., Martin-Jaular, L., Lavieu, G., Thery, C.: Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat. Cell Biol. 21, 9–17 (2019)
Zhang, H., et al.: Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat. Cell Biol. 20, 332–343 (2018)
Colombo, M., Raposo, G., Thery, C.: Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu. Rev. Cell Dev. Biol. 30, 255–289 (2014)
Al-Nedawi, K., et al.: Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat. Cell Biol. 10, 619–624 (2008)
Di Vizio, D., et al.: Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res. 69, 5601–5609 (2009)
Zhang, Q., et al.: Transfer of functional cargo in exomeres. Cell Rep. 27, 940–954 e946 (2019)
Johnstone, R.M.: The Jeanne Manery-Fisher Memorial Lecture 1991. Maturation of reticulocytes: formation of exosomes as a mechanism for shedding membrane proteins. Biochem. Cell Biol. 70, 179–190 (1992)
Harding, C., Heuser, J., Stahl, P.: Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J. Cell Biol. 97, 329–339 (1983)
Pan, B.T., Johnstone, R.M.: Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell. 33, 967–978 (1983)
Haraszti, R.A., et al.: High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources. J Extracell Vesicles. 5, 32570 (2016)
Zakharova, L., Svetlova, M., Fomina, A.F.: T cell exosomes induce cholesterol accumulation in human monocytes via phosphatidylserine receptor. J. Cell. Physiol. 212, 174–181 (2007)
Clement, E., et al.: Adipocyte extracellular vesicles carry enzymes and fatty acids that stimulate mitochondrial metabolism and remodeling in tumor cells. EMBO J. 39, e102525 (2020)
Steinbichler, T.B., Dudas, J., Riechelmann, H., Skvortsova, I.I.: The role of exosomes in cancer metastasis. Semin. Cancer Biol. 44, 170–181 (2017)
Tomasetti, M., Lee, W., Santarelli, L., Neuzil, J.: Exosome-derived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapy. Exp. Mol. Med. 49, e285 (2017)
Adem, B., Vieira, P.F., Melo, S.A.: Decoding the biology of exosomes in metastasis. Trends Cancer. 6, 20–30 (2020)
Daassi, D., Mahoney, K.M., Freeman, G.J.: The importance of exosomal PDL1 in tumour immune evasion. Nat. Rev. Immunol. (2020)
Kessenbrock, K., Plaks, V., Werb, Z.: Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 141, 52–67 (2010)
Ginestra, A., et al.: Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells. J. Biol. Chem. 272, 17216–17222 (1997)
Dolo, V., et al.: Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells. Cancer Res. 58, 4468–4474 (1998)
Shan, Y., et al.: Hypoxia-induced matrix metalloproteinase-13 expression in exosomes from nasopharyngeal carcinoma enhances metastases. Cell Death Dis. 9, 382 (2018)
Hakulinen, J., Sankkila, L., Sugiyama, N., Lehti, K., Keski-Oja, J.: Secretion of active membrane type 1 matrix metalloproteinase (MMP-14) into extracellular space in microvesicular exosomes. J. Cell. Biochem. 105, 1211–1218 (2008)
Mu, W., Rana, S., Zoller, M.: Host matrix modulation by tumor exosomes promotes motility and invasiveness. Neoplasia. 15, 875–887 (2013)
Redzic, J.S., et al.: Extracellular vesicles secreted from cancer cell lines stimulate secretion of MMP-9, IL-6, TGF-beta1 and EMMPRIN. PLoS One. 8, e71225 (2013)
Sanchez, C.A., et al.: Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche. Oncotarget. 7, 3993–4008 (2016)
Atay, S., et al.: Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion. Proc. Natl. Acad. Sci. USA. 111, 711–716 (2014)
Hinz, B., Celetta, G., Tomasek, J.J., Gabbiani, G., Chaponnier, C.: Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol. Biol. Cell. 12, 2730–2741 (2001)
Kalluri, R.: The biology and function of fibroblasts in cancer. Nat. Rev. Cancer. 16, 582–598 (2016)
Webber, J., Steadman, R., Mason, M.D., Tabi, Z., Clayton, A.: Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res. 70, 9621–9630 (2010)
Webber, J.P., et al.: Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes. Oncogene. 34, 290–302 (2015)
Ostrowski, M., et al.: Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol. 12, 19–30.; sup pp 11-13 (2010)
Zhou, Y., et al.: Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts. J. Exp. Clin. Cancer Res. 37, 324 (2018)
Paggetti, J., et al.: Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts. Blood. 126, 1106–1117 (2015)
Chowdhury, R., et al.: Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblasts. Oncotarget. 6, 715–731 (2015)
Cho, J.A., et al.: Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts. Gynecol. Oncol. 123, 379–386 (2011)
Vesely, M.D., Kershaw, M.H., Schreiber, R.D., Smyth, M.J.: Natural innate and adaptive immunity to cancer. Annu. Rev. Immunol. 29, 235–271 (2011)
Wildes, T.J., Flores, C.T., Mitchell, D.A.: Concise review: modulating cancer immunity with hematopoietic stem and progenitor cells. Stem Cells. 37, 166–175 (2019)
Gonzalez, H., Hagerling, C., Werb, Z.: Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev. 32, 1267–1284 (2018)
Wellenstein, M.D., de Visser, K.E.: Cancer-cell-intrinsic mechanisms shaping the tumor immune landscape. Immunity. 48, 399–416 (2018)
McGranahan, N., et al.: Allele-specific HLA loss and immune escape in lung cancer evolution. Cell. 171, 1259–1271 e1211 (2017)
Tauriello, D.V.F., et al.: TGFbeta drives immune evasion in genetically reconstituted colon cancer metastasis. Nature. 554, 538–543 (2018)
King, K.Y., Goodell, M.A.: Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat. Rev. Immunol. 11, 685–692 (2011)
Ortiz, A., et al.: An interferon-driven oxysterol-based defense against tumor-derived extracellular vesicles. Cancer Cell. 35, 33–45 e36 (2019)
Vivier, E., et al.: Innate or adaptive immunity? The example of natural killer cells. Science. 331, 44–49 (2011)
Hornick, N.I., et al.: AML suppresses hematopoiesis by releasing exosomes that contain microRNAs targeting c-MYB. Sci. Signal. 9, ra88 (2016)
Yu, S., et al.: Tumor exosomes inhibit differentiation of bone marrow dendritic cells. J. Immunol. 178, 6867–6875 (2007)
Xiang, X., et al.: Induction of myeloid-derived suppressor cells by tumor exosomes. Int. J. Cancer. 124, 2621–2633 (2009)
Gabrilovich, D.I.: Myeloid-derived suppressor cells. Cancer Immunol. Res. 5, 3–8 (2017)
Chalmin, F., et al.: Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J. Clin. Invest. 120, 457–471 (2010)
Fleming, V., et al.: Melanoma extracellular vesicles generate immunosuppressive myeloid cells by upregulating PD-L1 via TLR4 signaling. Cancer Res. 79, 4715–4728 (2019)
Huber, V., et al.: Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma. J. Clin. Invest. 128, 5505–5516 (2018)
Guo, X., et al.: Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways. Oncogene. 37, 4239–4259 (2018)
Akira, S., Uematsu, S., Takeuchi, O.: Pathogen recognition and innate immunity. Cell. 124, 783–801 (2006)
Vitale, I., Manic, G., Coussens, L.M., Kroemer, G., Galluzzi, L.: Macrophages and metabolism in the tumor microenvironment. Cell Metab. 30, 36–50 (2019)
Fabbri, M., et al.: MicroRNAs bind to toll-like receptors to induce prometastatic inflammatory response. Proc. Natl. Acad. Sci. USA. 109, E2110–E2116 (2012)
Ying, X., et al.: Epithelial ovarian cancer-secreted exosomal miR-222-3p induces polarization of tumor-associated macrophages. Oncotarget. 7, 43076–43087 (2016)
Cooks, T., et al.: Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246. Nat. Commun. 9, 771 (2018)
Park, J.E., et al.: Hypoxia-induced tumor exosomes promote M2-like macrophage polarization of infiltrating myeloid cells and microRNA-mediated metabolic shift. Oncogene. 38, 5158–5173 (2019)
Palucka, K., Banchereau, J.: Cancer immunotherapy via dendritic cells. Nat. Rev. Cancer. 12, 265–277 (2012)
Yu, S., et al.: EGFR E746-A750 deletion in lung cancer represses antitumor immunity through the exosome-mediated inhibition of dendritic cells. Oncogene. (2020)
Ding, G., et al.: Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p. Oncotarget. 6, 29877–29888 (2015)
Guillerey, C., Huntington, N.D., Smyth, M.J.: Targeting natural killer cells in cancer immunotherapy. Nat. Immunol. 17, 1025–1036 (2016)
Baginska, J., et al.: The critical role of the tumor microenvironment in shaping natural killer cell-mediated anti-tumor immunity. Front. Immunol. 4, 490 (2013)
Han, B., et al.: Altered NKp30, NKp46, NKG2D, and DNAM-1 expression on circulating NK cells is associated with tumor progression in human gastric cancer. J Immunol Res. 2018, 6248590 (2018)
Viel, S., et al.: TGF-beta inhibits the activation and functions of NK cells by repressing the mTOR pathway. Sci. Signal. 9, ra19 (2016)
Zhao, J.G., et al.: Tumor-derived extracellular vesicles inhibit natural killer cell function in pancreatic cancer. Cancers. 11 (2019)
Lundholm, M., et al.: Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: mechanism of immune evasion. PLoS One. 9, e108925 (2014)
Liu, C., et al.: Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J. Immunol. 176, 1375–1385 (2006)
Coffelt, S.B., Wellenstein, M.D., de Visser, K.E.: Neutrophils in cancer: neutral no more. Nat. Rev. Cancer. 16, 431–446 (2016)
Kowanetz, M., et al.: Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes. Proc. Natl. Acad. Sci. USA. 107, 21248–21255 (2010)
Granot, Z., et al.: Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell. 20, 300–314 (2011)
Li, Y.W., et al.: Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection. J. Hepatol. 54, 497–505 (2011)
Zhao, J.J., et al.: The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection. PLoS One. 7, e33655 (2012)
Jensen, H.K., et al.: Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J. Clin. Oncol. 27, 4709–4717 (2009)
Schmidt, H., et al.: Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model. Br. J. Cancer. 93, 273–278 (2005)
Casbon, A.J., et al.: Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils. Proc. Natl. Acad. Sci. USA. 112, E566–E575 (2015)
Bayne, L.J., et al.: Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell. 21, 822–835 (2012)
Coffelt, S.B., et al.: IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis. Nature. 522, 345–348 (2015)
Wang, D., Sun, H., Wei, J., Cen, B., DuBois, R.N.: CXCL1 is critical for premetastatic niche formation and metastasis in colorectal cancer. Cancer Res. 77, 3655–3665 (2017)
Shaul, M.E., Fridlender, Z.G.: Tumour-associated neutrophils in patients with cancer. Nat. Rev. Clin. Oncol. 16, 601–620 (2019)
Andzinski, L., et al.: Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human. Int. J. Cancer. 138, 1982–1993 (2016)
Fridlender, Z.G., et al.: Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN. Cancer Cell. 16, 183–194 (2009)
Zhang, X., et al.: Tumor-derived exosomes induce N2 polarization of neutrophils to promote gastric cancer cell migration. Mol. Cancer. 17, 146 (2018)
Hwang, W.L., Lan, H.Y., Cheng, W.C., Huang, S.C., Yang, M.H.: Tumor stem-like cell-derived exosomal RNAs prime neutrophils for facilitating tumorigenesis of colon cancer. J. Hematol. Oncol. 12, 10 (2019)
Leal, A.C., et al.: Tumor-derived exosomes induce the formation of neutrophil extracellular traps: implications for the establishment of cancer-associated thrombosis. Sci. Rep. 7, 6438 (2017)
Brinkmann, V., et al.: Neutrophil extracellular traps kill bacteria. Science. 303, 1532–1535 (2004)
Demers, M., et al.: Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc. Natl. Acad. Sci. USA. 109, 13076–13081 (2012)
Park, J., et al.: Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps. Sci. Transl. Med. 8, 361ra138 (2016)
Cools-Lartigue, J., et al.: Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J. Clin. Invest. (2013)
Litman, G.W., Rast, J.P., Fugmann, S.D.: The origins of vertebrate adaptive immunity. Nat. Rev. Immunol. 10, 543–553 (2010)
Razzo, B.M., et al.: Tumor-derived exosomes promote carcinogenesis of murine oral squamous cell carcinoma. Carcinogenesis. (2019)
Wang, X., et al.: 14-3-3zeta delivered by hepatocellular carcinoma-derived exosomes impaired anti-tumor function of tumor-infiltrating T lymphocytes. Cell Death Dis. 9, 159 (2018)
Mirzaei, R., et al.: Brain tumor-initiating cells export tenascin-C associated with exosomes to suppress T cell activity. Onco. Targets. Ther. 7, e1478647 (2018)
Griss, J., et al.: B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma. Nat. Commun. 10, 4186 (2019)
Garaud, S., et al.: Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer. JCI Insight. 5 (2019)
Meng, Q., Valentini, D., Rao, M., Maeurer, M.: KRAS renaissance(s) in tumor infiltrating B cells in pancreatic cancer. Front. Oncol. 8, 384 (2018)
Pylayeva-Gupta, Y., et al.: IL35-producing B cells promote the development of pancreatic neoplasia. Cancer Discov. 6, 247–255 (2016)
Xiao, X., et al.: PD-1hi identifies a novel regulatory B-cell population in human hepatoma that promotes disease progression. Cancer Discov. 6, 546–559 (2016)
Ye, L., et al.: Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1(+) regulatory B cell expansion. J. Immunother. Cancer. 6, 145 (2018)
Katoh, M.: Therapeutics targeting angiogenesis: genetics and epigenetics, extracellular miRNAs and signaling networks (Review). Int. J. Mol. Med. 32, 763–767 (2013)
De Palma, M., Biziato, D., Petrova, T.V.: Microenvironmental regulation of tumour angiogenesis. Nat. Rev. Cancer. 17, 457–474 (2017)
Sawamiphak, S., et al.: Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature. 465, 487–491 (2010)
Sato, S., et al.: EPHB2 carried on small extracellular vesicles induces tumor angiogenesis via activation of ephrin reverse signaling. JCI Insight. 4 (2019)
Jung, K.O., Youn, H., Lee, C.H., Kang, K.W., Chung, J.K.: Visualization of exosome-mediated miR-210 transfer from hypoxic tumor cells. Oncotarget. 8, 9899–9910 (2017)
Lanahan, A.A., et al.: PTP1b is a physiologic regulator of vascular endothelial growth factor signaling in endothelial cells. Circulation. 130, 902–909 (2014)
Umezu, T., et al.: Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 124, 3748–3757 (2014)
Li, B.B., et al.: piRNA-823 delivered by multiple myeloma-derived extracellular vesicles promoted tumorigenesis through re-educating endothelial cells in the tumor environment. Oncogene. 38, 5227–5238 (2019)
Treps, L., Perret, R., Edmond, S., Ricard, D., Gavard, J.: Glioblastoma stem-like cells secrete the pro-angiogenic VEGF-A factor in extracellular vesicles. J. Extracell. Vesicles. 6, 1359479 (2017)
Ko, S.Y., et al.: Cancer-derived small extracellular vesicles promote angiogenesis by heparin-bound, bevacizumab-insensitive VEGF, independent of vesicle uptake. Commun. Biol. 2, 386 (2019)
Strilic, B., Offermanns, S.: Intravascular survival and extravasation of tumor cells. Cancer Cell. 32, 282–293 (2017)
Mohme, M., Riethdorf, S., Pantel, K.: Circulating and disseminated tumour cells – mechanisms of immune surveillance and escape. Nat. Rev. Clin. Oncol. 14, 155–167 (2017)
Treps, L., et al.: Extracellular vesicle-transported Semaphorin3A promotes vascular permeability in glioblastoma. Oncogene. 35, 2615–2623 (2016)
Zeng, Z., et al.: Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis. Nat. Commun. 9, 5395 (2018)
Bhattacharya, R., et al.: Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kruppel-like factor KLF2. J. Biol. Chem. 280, 28848–28851 (2005)
Ma, J., et al.: Kruppel-like factor 4 regulates blood-tumor barrier permeability via ZO-1, occludin and claudin-5. J. Cell. Physiol. 229, 916–926 (2014)
Hsu, Y.L., et al.: Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1. Oncogene. 36, 4929–4942 (2017)
Di Modica, M., et al.: Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers. Cancer Lett. 384, 94–100 (2017)
Fang, J.H., et al.: Hepatoma cell-secreted exosomal microRNA-103 increases vascular permeability and promotes metastasis by targeting junction proteins. Hepatology. 68, 1459–1475 (2018)
Li, J., et al.: Circular RNA IARS (circ-IARS) secreted by pancreatic cancer cells and located within exosomes regulates endothelial monolayer permeability to promote tumor metastasis. J. Exp. Clin. Cancer Res. 37 (2018)
Hansen, T.B., et al.: Natural RNA circles function as efficient microRNA sponges. Nature. 495, 384–388 (2013)
Fidler, I.J., Nicolson, G.L.: Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines. J. Natl. Cancer Inst. 57, 1199–1202 (1976)
Hart, I.R., Fidler, I.J.: Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Res. 40, 2281–2287 (1980)
Gao, Y., et al.: Metastasis organotropism: redefining the congenial soil. Dev. Cell. 49, 375–391 (2019)
Nguyen, D.X., Bos, P.D., Massague, J.: Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer. 9, 274–U265 (2009)
Hood, J.L., San, R.S., Wickline, S.A.: Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res. 71, 3792–3801 (2011)
Xiao, Z., et al.: Molecular mechanism underlying lymphatic metastasis in pancreatic cancer. Biomed. Res. Int. 2014, 925845 (2014)
Pucci, F., et al.: SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions. Science. 352, 242–246 (2016)
Maus, R.L.G., et al.: Human melanoma-derived extracellular vesicles regulate dendritic cell maturation. Front. Immunol. 8, 358 (2017)
Rana, S., Malinowska, K., Zoller, M.: Exosomal tumor microRNA modulates premetastatic organ cells. Neoplasia. 15, 281–295 (2013)
Srinivasan, S., Vannberg, F.O., Dixon, J.B.: Lymphatic transport of exosomes as a rapid route of information dissemination to the lymph node. Sci. Rep. 6, 24436 (2016)
Chen, C., et al.: Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer. J. Clin. Invest. 130, 404–421 (2020)
Sun, B., et al.: Colorectal cancer exosomes induce lymphatic network remodeling in lymph nodes. Int. J. Cancer. 145, 1648–1659 (2019)
Randolph, G.J., Ivanov, S., Zinselmeyer, B.H., Scallan, J.P.: The lymphatic system: integral roles in immunity. Annu. Rev. Immunol. 35, 31–52 (2017)
Chow, A., et al.: Macrophage immunomodulation by breast cancer-derived exosomes requires toll-like receptor 2-mediated activation of NF-kappaB. Sci. Rep. 4, 5750 (2014)
Muhsin-Sharafaldine, M.R., Saunderson, S.C., Dunn, A.C., McLellan, A.D.: Melanoma growth and lymph node metastasis is independent of host CD169 expression. Biochem. Biophys. Res. Commun. 486, 965–970 (2017)
Skobe, M., et al.: Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 7, 192–198 (2001)
Stacker, S.A., et al.: VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med. 7, 186–191 (2001)
Stacker, S.A., et al.: Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat. Rev. Cancer. 14, 159–172 (2014)
Park, R.J., Hong, Y.J., Wu, Y., Kim, P.M., Hong, Y.K.: Exosomes as a communication tool between the lymphatic system and bladder cancer. Int. Neurourol. J. 22, 220–224 (2018)
Zhou, C.F., et al.: Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1. Oncogene. 38, 1256–1268 (2019)
Hautmann, R.E., de Petriconi, R.C., Pfeiffer, C., Volkmer, B.G.: Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. Eur. Urol. 61, 1039–1047 (2012)
Liu, D., et al.: CD97 promotion of gastric carcinoma lymphatic metastasis is exosome dependent. Gastric Cancer. 19, 754–766 (2016)
Morton, D.L., et al.: Sentinel-node biopsy or nodal observation in melanoma. N. Engl. J. Med. 355, 1307–1317 (2006)
Cheng, L., et al.: Cancer volume of lymph node metastasis predicts progression in prostate cancer. Am. J. Surg. Pathol. 22, 1491–1500 (1998)
Im, E.J., et al.: Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A. Nat. Commun. 10, 1387 (2019)
Altorki, N.K., et al.: The lung microenvironment: an important regulator of tumour growth and metastasis. Nat. Rev. Cancer. 19, 9–31 (2019)
Erler, J.T., et al.: Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell. 15, 35–44 (2009)
Fang, T., et al.: Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer. Nat. Commun. 9, 191 (2018)
Trefts, E., Gannon, M., Wasserman, D.H.: The liver. Curr. Biol. 27, R1147–R1151 (2017)
Zhang, H., et al.: Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis. Nat. Commun. 8, 15016 (2017)
Shao, Y., et al.: Colorectal cancer-derived small extracellular vesicles establish an inflammatory premetastatic niche in liver metastasis. Carcinogenesis. 39, 1368–1379 (2018)
Mundy, G.R.: Metastasis to bone: causes, consequences and therapeutic opportunities. Nat. Rev. Cancer. 2, 584–593 (2002)
Cao, X.: RANKL-RANK signaling regulates osteoblast differentiation and bone formation. Bone Res. 6, 35 (2018)
Tiedemann, K., et al.: Exosomal release of L-plastin by breast cancer cells facilitates metastatic bone osteolysis. Transl. Oncol. 12, 462–474 (2019)
Guo, L., et al.: Breast cancer cell-derived exosomal miR-20a-5p promotes the proliferation and differentiation of osteoclasts by targeting SRCIN1. Cancer Med. 8, 5687–5701 (2019)
Probert, C., et al.: Communication of prostate cancer cells with bone cells via extracellular vesicle RNA; a potential mechanism of metastasis. Oncogene. 38, 1751–1763 (2019)
Ye, Y., et al.: Exosomal miR-141-3p regulates osteoblast activity to promote the osteoblastic metastasis of prostate cancer. Oncotarget. 8, 94834–94849 (2017)
Lacey, D.L., et al.: Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab. Nat. Rev. Drug Discov. 11, 401–419 (2012)
Hashimoto, K., et al.: Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A. Proc. Natl. Acad. Sci. USA. 115, 2204–2209 (2018)
Tominaga, N., et al.: Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier. Nat. Commun. 6, 6716 (2015)
Xing, F., et al.: Loss of XIST in breast cancer activates MSN-c-Met and reprograms microglia via exosomal miRNA to promote brain metastasis. Cancer Res. 78, 4316–4330 (2018)
Gener Lahav, T., et al.: Melanoma-derived extracellular vesicles instigate proinflammatory signaling in the metastatic microenvironment. Int. J. Cancer. 145, 2521–2534 (2019)
Sweeney, M.D., Zhao, Z., Montagne, A., Nelson, A.R., Zlokovic, B.V.: Blood-brain barrier: from physiology to disease and back. Physiol. Rev. 99, 21–78 (2019)
Morad, G., et al.: Tumor-derived extracellular vesicles breach the intact blood-brain barrier via transcytosis. ACS Nano. 13, 13853–13865 (2019)
Xu, Z.H., et al.: Brain microvascular endothelial cell exosome-mediated S100A16 up-regulation confers small-cell lung cancer cell survival in brain. FASEB J. 33, 1742–1757 (2019)
Zhang, L., et al.: Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature. 527, 100–104 (2015)
Chen, G., et al.: Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature. 560, 382–386 (2018)
Balaj, L., et al.: Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat. Commun. 2, 180 (2011)
Guescini, M., Genedani, S., Stocchi, V., Agnati, L.F.: Astrocytes and Glioblastoma cells release exosomes carrying mtDNA. J. Neural Transm. (Vienna). 117, 1–4 (2010)
Thakur, B.K., et al.: Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res. 24, 766–769 (2014)
Sharma, A., Johnson, A.: Exosome DNA: critical regulator of tumor immunity and a diagnostic biomarker. J. Cell. Physiol. 235, 1921–1932 (2020)
Kitai, Y., et al.: DNA-containing exosomes derived from cancer cells treated with topotecan activate a STING-dependent pathway and reinforce antitumor immunity. J. Immunol. 198, 1649–1659 (2017)
Xu, M.M., et al.: Dendritic cells but not macrophages sense tumor mitochondrial DNA for cross-priming through signal regulatory protein alpha signaling. Immunity. 47, 363-+ (2017)
Puhka, M., et al.: Metabolomic profiling of extracellular vesicles and alternative normalization methods reveal enriched metabolites and strategies to study prostate cancer-related changes. Theranostics. 7, 3824–3841 (2017)
Lai, C.P., et al.: Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters. Nat. Commun. 6, 7029 (2015)
Zomer, A., et al.: In vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior. Cell. 161, 1046–1057 (2015)
Zomer, A., Steenbeek, S.C., Maynard, C., van Rheenen, J.: Studying extracellular vesicle transfer by a Cre-loxP method. Nat. Protoc. 11, 87–101 (2016)
Hyenne, V., et al.: Studying the fate of tumor extracellular vesicles at high spatiotemporal resolution using the zebrafish embryo. Dev. Cell. 48, 554–572 e557 (2019)
Fearon, K.C., Glass, D.J., Guttridge, D.C.: Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab. 16, 153–166 (2012)
Porporato, P.E.: Understanding cachexia as a cancer metabolism syndrome. Oncogenesis. 5 (2016)
Wang, G., et al.: Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle. Nat. Med. 24, 770–781 (2018)
Baracos, V.E., Martin, L., Korc, M., Guttridge, D.C., Fearon, K.C.H.: Cancer-associated cachexia. Nat. Rev. Dis. Primers. 4, 17105 (2018)
Miao, C., et al.: Cancer-derived exosome miRNAs induce skeletal muscle wasting by Bcl-2-mediated apoptosis in colon cancer cachexia. Mol. Ther. Nucleic Acids. 24, 923–938 (2021)
Zhang, G., et al.: Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90. Nat. Commun. 8, 589 (2017)
He, W.A., et al.: Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7. Proc. Natl. Acad. Sci. USA. 111, 4525–4529 (2014)
Sagar, G., et al.: Pathogenesis of pancreatic cancer exosome-induced lipolysis in adipose tissue. Gut. 65, 1165–1174 (2016)
Wang, S., Li, X., Xu, M., Wang, J., Zhao, R.C.: Reduced adipogenesis after lung tumor exosomes priming in human mesenchymal stem cells via TGFbeta signaling pathway. Mol. Cell. Biochem. 435, 59–66 (2017)
Petruzzelli, M., et al.: A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell Metab. 20, 433–447 (2014)
Wu, Q., et al.: Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression. Mol. Cancer. 17, 155 (2018)
Di, W.J., et al.: Colorectal cancer prompted adipose tissue browning and cancer cachexia through transferring exosomal miR-146b-5p. J. Cell. Physiol. 236, 5399–5410 (2021)
Manger, B., Schett, G.: Paraneoplastic syndromes in rheumatology. Nat. Rev. Rheumatol. 10, 662–670 (2014)
Javeed, N., et al.: Pancreatic cancer-derived exosomes cause paraneoplastic beta-cell dysfunction. Clin. Cancer Res. 21, 1722–1733 (2015)
Lima, L.G., Leal, A.C., Vargas, G., Porto-Carreiro, I., Monteiro, R.Q.: Intercellular transfer of tissue factor via the uptake of tumor-derived microvesicles. Thromb. Res. 132, 450–456 (2013)
Gomes, F.G., et al.: Breast-cancer extracellular vesicles induce platelet activation and aggregation by tissue factor-independent and -dependent mechanisms. Thromb. Res. 159, 24–32 (2017)
Wefel, J.S., Vardy, J., Ahles, T., Schagen, S.B.: International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol. 12, 703–708 (2011)
Koh, Y.Q., et al.: Role of exosomes in cancer-related cognitive impairment. Int. J. Mol. Sci. 21 (2020)
Jabbari, N., Nawaz, M., Rezaie, J.: Ionizing radiation increases the activity of exosomal secretory pathway in MCF-7 human breast cancer cells: a possible way to communicate resistance against radiotherapy. Int. J. Mol. Sci. 20 (2019)
Bandari, S.K., et al.: Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior. Matrix Biol. 65, 104–118 (2018)
Chen, E.I., et al.: Identifying predictors of taxane-induced peripheral neuropathy using mass spectrometry-based proteomics technology. PLoS One. 10 (2015)
LeBleu, V.S., Kalluri, R.: Exosomes as a multicomponent biomarker platform in cancer. Trends Cancer. (2020)
Zhang, W., et al.: MicroRNAs in serum exosomes as potential biomarkers in clear-cell renal cell carcinoma. Eur. Urol. Focus. 4, 412–419 (2018)
Yang, K.S., et al.: Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy. Sci. Transl. Med. 9 (2017)
Li, P., Kaslan, M., Lee, S.H., Yao, J., Gao, Z.: Progress in exosome isolation techniques. Theranostics. 7, 789–804 (2017)
Senkus, E., Jassem, J.: Cardiovascular effects of systemic cancer treatment. Cancer Treat. Rev. 37, 300–311 (2011)
Sanmamed, M.F., Chen, L.: A paradigm shift in cancer immunotherapy: from enhancement to normalization. Cell. 175, 313–326 (2018)
Chen, L., Han, X.: Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future. J. Clin. Invest. 125, 3384–3391 (2015)
Page, D.B., Postow, M.A., Callahan, M.K., Allison, J.P., Wolchok, J.D.: Immune modulation in cancer with antibodies. Annu. Rev. Med. 65, 185–202 (2014)
Poggio, M., et al.: Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory. Cell. 177, 414–427 e413 (2019)
Luan, X., et al.: Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol. Sin. 38, 754–763 (2017)
Lin, X., DeAngelis, L.M.: Treatment of brain metastases. J. Clin. Oncol. 33, 3475–3484 (2015)
Tian, Y., et al.: A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials. 35, 2383–2390 (2014)
Kamerkar, S., et al.: Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 546, 498–503 (2017)
Munagala, R., et al.: Exosomal formulation of anthocyanidins against multiple cancer types. Cancer Lett. 393, 94–102 (2017)
Acknowledgments
The authors gratefully acknowledge support from the following funding sources: the National Cancer Institute CA224175 (to D.L.), CA210240 (to D.L.), CA232093 (to D.L.), CA163117 (to D.L.), CA207983 (to D.L.), CA163120 (to D.L.), CA169416 (to D.L.), CA169538 (to D.L.), CA218513 (to D.L. and H.Z.) and AI144301 (to D.L.), the United States Department of Defense (W81XWH-13-1-0425, W81XWH-13-1-0427, W81XWH-13-1-0249 and W81XWH-14-1-0199 (to D.L.)), the Malcolm Hewitt Weiner Foundation (to D.L.), the Hartwell Foundation (to D.L.), the Manning Foundation (to D.L.), the Thompson Family Foundation (to D.L.), The Daniel P. and Nancy C. Paduano Family Foundation (to D.L.), the James Paduano Foundation (to D.L.), the Sohn Foundation (to D.L.), the STARR Consortium I9-A9-056 (to D.L. and H.Z.), the STARR Consortium I8-A8-123 (to D.L.), the AHEPA Vth District Cancer Research Foundation (to D.L.), the Pediatric Oncology Experimental Therapeutics Investigator’s Consortium (to D.L.), the Alex’s Lemonade Stand Foundation (to D.L.), the Breast Cancer Research Foundation (to D.L.), the Daedalus Fund (Weill Cornell Medicine, to D.L.), the Feldstein Medical Foundation (to D.L.), the Tortolani Foundation (to D.L.), the Children’s Cancer and Blood Foundation (to D.L.), the Clinical & Translational Science Center (to D.L. and H.Z.), the Mary K. Ash Charitable Foundation (to D.L.), the Selma and Lawrence Ruben Science to Industry Bridge Fund (to D.L.). Figures were created using the templates from Servier Medical Art, licensed under a Creative Commons Attribution 3.0 Unported License; https://smart.servier.com.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Wang, G., Kenific, C.M., Lieberman, G., Zhang, H., Lyden, D. (2022). Systemic Regulation of Metastatic Disease by Extracellular Vesicles and Particles. In: Acharyya, S. (eds) The Systemic Effects of Advanced Cancer. Springer, Cham. https://doi.org/10.1007/978-3-031-09518-4_2
Download citation
DOI: https://doi.org/10.1007/978-3-031-09518-4_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-07272-7
Online ISBN: 978-3-031-09518-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)